Released on: June 16, 2008, 11:26 pm

Press Release Author: Shushmul Maheshwari

Industry: Healthcare

Press Release Summary: The Point of Care Diagnostics market is expected to account
for around 34% share in the global IVD market on the back of multiple benefits it
offers, says new research by RNCOS.

Press Release Body: The leading market research firm RNCOS has launched its new
report, “Global In Vitro Diagnostic Market Analysis”, that anticipates
the worldwide In Vitro Diagnostic (IVD) market to hit the total revenues of about
US$ 53 Billion by 2012. Out of this, Point of Care Diagnostics (POCT) currently
makes up for the largest share in the global IVD market and is projected to maintain
its share during the forecasted period.

POCT is real-time diagnostic testing which is performed near to or at the
patient’s site with the result may leading to a change in the patient’s
treatment.

According to the RNCOS research, POCT is one of the fastest growing and biggest
segments of the IVD market. The segment accounted for around 33.4% of the total
market in 2007. The POCT segment is forecasted to gain more popularity in future due
to the multitude of benefits its offers, including faster results, availability of
new computer systems and biosensor technologies, rising adoption of self-testing
products, and improving demand for more efficient testing methods by physicians.

As a result, revenues from the POCT market are forecasted to register CAGR growth of
nearly 6.9%, higher than the overall market’s growth (in CAGR terms) of around
6.7%. Blood glucose testing, which contributed 70% share in the POCT market, is
likely to remain the largest segment in future, while cardiac markers with 3% share
are expected to emerge as the fastest growing one.

“Global In Vitro Diagnostic Market Analysis” provides comprehensive and
detailed overview on the global IVD market with thorough analysis on traditional IVD
market, new emerging technologies, market size, growth, share, geographical
distribution, segmentation, growth factors, trends and challenges for the
development of the market. The report also gives forecast on regional IVD market,
segment-wise (clinical segment) IVD market, like molecular diagnostics, immune
chemistry, clinical chemistry, microbiology and blood screen immunoassays.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://rncos.com/Report/IM103.htm
Current Industry News: http://www.rncos.com/Blog/

Web Site: http://www.rncos.com

Contact Details: 29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
91-11-4214-1228
info@rncos.com

http://www.rncos.com/